Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Nausea from GLP-1 receptor agonists is usually transient and diminishes significantly within 48 weeks as the body adapts to the medication
The first-time AOM semaglutide prescribing rate was 0.1% in January 2024 and reached 0.2% by July 2024
Because retatrutide includes GLP-1 agonism (which semaglutide was providing) plus GIP and glucagon agonism, the transition should not result in loss of appetite suppression during the switch
We will always set realistic expectations and prioritize your safety
Current clinical research suggests that retatrutide may produce greater average weight loss than semaglutide
US$ 28.03
US$ 21.36
US$ 29.96
US$ 23.23
US$ 23.77
US$ 25.01
US$ 28.13
US$ 27.30
